Yousif Capital Management LLC Sells 384 Shares of STERIS plc (NYSE:STE)

Yousif Capital Management LLC lowered its holdings in STERIS plc (NYSE:STE) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,283 shares of the medical equipment provider’s stock after selling 384 shares during the quarter. Yousif Capital Management LLC’s holdings in STERIS were worth $3,360,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also bought and sold shares of STE. Fortune Financial Advisors LLC lifted its holdings in STERIS by 0.7% during the third quarter. Fortune Financial Advisors LLC now owns 7,022 shares of the medical equipment provider’s stock valued at $1,541,000 after purchasing an additional 47 shares in the last quarter. Greenleaf Trust boosted its holdings in STERIS by 2.8% in the 3rd quarter. Greenleaf Trust now owns 1,888 shares of the medical equipment provider’s stock worth $414,000 after buying an additional 51 shares during the period. Park Edge Advisors LLC increased its stake in STERIS by 1.2% in the 4th quarter. Park Edge Advisors LLC now owns 4,409 shares of the medical equipment provider’s stock worth $969,000 after buying an additional 51 shares in the last quarter. UMB Bank n.a. raised its holdings in STERIS by 7.8% during the fourth quarter. UMB Bank n.a. now owns 716 shares of the medical equipment provider’s stock valued at $157,000 after acquiring an additional 52 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of STERIS by 0.6% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 8,944 shares of the medical equipment provider’s stock valued at $1,962,000 after acquiring an additional 54 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

STE has been the topic of several recent analyst reports. KeyCorp assumed coverage on STERIS in a research note on Tuesday, February 6th. They set an “overweight” rating and a $253.00 target price on the stock. Stephens reiterated an “overweight” rating and issued a $250.00 price target on shares of STERIS in a report on Friday, February 9th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, April 12th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 8th. Finally, TheStreet raised STERIS from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $239.60.

STERIS Trading Up 1.2 %

Shares of NYSE STE opened at $203.90 on Monday. STERIS plc has a 1-year low of $181.78 and a 1-year high of $254.00. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. The business’s 50 day moving average is $221.18 and its two-hundred day moving average is $216.67. The stock has a market capitalization of $20.15 billion, a P/E ratio of 35.71 and a beta of 0.79.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, beating the consensus estimate of $2.17 by $0.05. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the previous year, the company posted $2.02 EPS. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. As a group, research analysts expect that STERIS plc will post 8.67 EPS for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, February 23rd were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 22nd. STERIS’s dividend payout ratio is currently 36.43%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.